Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.57 |
| ▸ | IDO1 | P14902 | 3/20 | 0.52 |
| ▸ | AGXT | P21549 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.46 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27884 | 0.81 | LTA4H (0.81) | LTA4HIDO1AGXTCA12CA1 | |
| SCHEMBL1425001 | 0.81 | LTA4H (0.81) | LTA4HIDO1AGXTCA12CA1 | |
| SCHEMBL2562715 | 0.81 | TAAR1 (0.55) | IDO1TAAR1SIGMAR1 | |
| Ammonia Solution, Strong SCHEMBL20919857 | 0.79 | LTA4H (0.77) | LTA4HIDO1AGXTCA12CA1 | |
| SCHEMBL2563224 | 0.78 | CALM1 (0.61) | TAAR1SIGMAR1ALOX15 | |
| SCHEMBL21994566 | 0.76 | LTA4H (0.59) | LTA4HIDO1AGXTCA12CA1 | |
| SCHEMBL24321390 | 0.75 | LTA4H (0.71) | LTA4HIDO1AGXTCA12CA1 | |
| SCHEMBL22451382 | 0.75 | LTA4H (0.71) | LTA4HIDO1AGXTCA12CA1 | |
| SCHEMBL6059611 | 0.75 | LTA4H (0.71) | LTA4HIDO1AGXTCA12CA1 | |
| SCHEMBL9235879 | 0.75 | LTA4H (0.71) | LTA4HIDO1AGXTCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9072293-B2 | Cyclopropenes and method for applying cyclopropenes to agricultural products or crops | ERUM BIOTECHNOLOGIES INC. (KR) | 2015-07-07 | — | — | US | disclosed |
| CN-102843906-B | Cyclopropene compounds and methods of adding the compounds to agricultural crops | ERUM BIOTECHNOLOGIES INC | 2015-07-01 | — | — | CN | disclosed |
| EP-2561754-A2 | CYCLOPROPENE COMPOUND, AND METHOD FOR ADDING SAME TO CROPS | Erum Biotechnologies Inc. (KR) | 2013-02-27 | — | — | EP | disclosed |
| CN-102843906-A | Cyclopropene compounds and methods of adding the compounds to agricultural crops | ERUM BIOTECHNOLOGIES INC | 2012-12-26 | — | — | CN | disclosed |
| US-20120322662-A1 | CYCLOPROPENES AND METHOD FOR APPLYING CYCLOPROPENES TO AGRICULTURAL PRODUCTS OR CROPS | ERUM BIOTECHNOLOGIES INC. (KR) | 2012-12-20 | — | — | US | disclosed |
| WO-2011132888-A2 | CYCLOPROPENE COMPOUND, AND METHOD FOR ADDING SAME TO CROPS | (주) 이룸바이오테크놀러지 (KR) | 2011-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120322662-A1 | CYCLOPROPENES AND METHOD FOR APPLYING CYCLOPROPENES TO AGRICULTURAL PRODUCTS OR CROPS | GLA, PFAS, AMY1A | LTA4H 1014/4885IDO1 2328/4885AGXT 1887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.